These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Psychological resources protect health: 5-year survival and immune function among HIV-infected women from four US cities. Ickovics JR; Milan S; Boland R; Schoenbaum E; Schuman P; Vlahov D; AIDS; 2006 Sep; 20(14):1851-60. PubMed ID: 16954726 [TBL] [Abstract][Full Text] [Related]
4. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). Solomon L; Stein M; Flynn C; Schuman P; Schoenbaum E; Moore J; Holmberg S; Graham NM J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):253-61. PubMed ID: 9495226 [TBL] [Abstract][Full Text] [Related]
6. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Evans DL; Ten Have TR; Douglas SD; Gettes DR; Morrison M; Chiappini MS; Brinker-Spence P; Job C; Mercer DE; Wang YL; Cruess D; Dube B; Dalen EA; Brown T; Bauer R; Petitto JM Am J Psychiatry; 2002 Oct; 159(10):1752-9. PubMed ID: 12359683 [TBL] [Abstract][Full Text] [Related]
7. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389 [TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand. Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412 [TBL] [Abstract][Full Text] [Related]
9. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. Phillips AN; Staszewski S; Weber R; Kirk O; Francioli P; Miller V; Vernazza P; Lundgren JD; Ledergerber B; ; ; JAMA; 2001 Nov; 286(20):2560-7. PubMed ID: 11722270 [TBL] [Abstract][Full Text] [Related]
10. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B; Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763 [TBL] [Abstract][Full Text] [Related]
11. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. Tang AM; Graham NM; Chandra RK; Saah AJ J Nutr; 1997 Feb; 127(2):345-51. PubMed ID: 9039838 [TBL] [Abstract][Full Text] [Related]
12. Association between Use of Methadone, Other Central Nervous System Depressants, and QTc Interval-Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus Infection. Tamraz B; Reisner L; French AL; King ST; Fischl MA; Ofotokun I; Kashuba A; Milam J; Murphy K; Augenbraun M; Liu C; Finley PR; Aouizerat B; Cocohoba J; Gange S; Bacchetti P; Greenblatt RM Pharmacotherapy; 2019 Sep; 39(9):899-911. PubMed ID: 31332819 [TBL] [Abstract][Full Text] [Related]
13. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy. Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148 [TBL] [Abstract][Full Text] [Related]
14. The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Kapadia F; Cook JA; Cohen MH; Sohler N; Kovacs A; Greenblatt RM; Choudhary I; Vlahov D Addiction; 2005 Jul; 100(7):990-1002. PubMed ID: 15955015 [TBL] [Abstract][Full Text] [Related]
15. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [TBL] [Abstract][Full Text] [Related]
16. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A JAMA; 1999 Dec; 282(23):2220-6. PubMed ID: 10605973 [TBL] [Abstract][Full Text] [Related]
17. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl. Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062 [TBL] [Abstract][Full Text] [Related]
18. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852 [TBL] [Abstract][Full Text] [Related]
19. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384 [TBL] [Abstract][Full Text] [Related]
20. Clinical importance of HIV and depressive symptoms among veterans with HIV infection. Kilbourne AM; Justice AC; Rollman BL; McGinnis KA; Rabeneck L; Weissman S; Smola S; Schultz R; Whittle J; Rodriguez-Barradas M J Gen Intern Med; 2002 Jul; 17(7):512-20. PubMed ID: 12133141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]